Axon Enterprise
AXON
$311.26
Share price
0.98%
Change (1 day)
47.72%
Change (1 year)
Axon Enterprise (AXON) - Total debt
Total debt on the balance sheet as of December 2023 : $0.71 B
According to Axon Enterprise 's latest financial reports the company's total debt is $0.71 B. A company’s total debt is the sum of all current and non-current debts.
Axon Enterprise - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.71 B | -0.06% |
| 2022-12-31 | $0.71 B | 3379.01% |
| 2021-12-31 | $20.44 M | |
| 2017-12-31 | $0.04 M | -65.25% |
| 2016-12-31 | $0.11 M | 45.68% |
| 2015-12-31 | $0.08 M | 20.9% |
| 2014-12-31 | $0.06 M | -34.95% |
| 2013-12-31 | $0.1 M | -24.82% |
| 2012-12-31 | $0.13 M | |
| 2011-12-31 | $N/A | |
| 2007-12-31 | $0.03 M | -59.37% |
| 2006-12-31 | $0.07 M | -36.14% |
| 2005-12-31 | $0.11 M | 2469.99% |
| 2004-12-31 | $0 M | -98.27% |
| 2003-12-31 | $0.26 M | -38.6% |
| 2002-12-31 | $0.43 M | -66.81% |
| 2001-12-31 | $1.31 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 XBiotech XBIT | N/A | N/A | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $38.1 M | -94.64% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Exelixis EXEL | $0.18 B | -73.27% | 🇺🇸 USA |